Camp4 Therapeutics (CAMP) Common Equity (2023 - 2025)
Historic Common Equity for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $58.7 million.
- Camp4 Therapeutics' Common Equity rose 13690.33% to $58.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $58.7 million, marking a year-over-year increase of 13690.33%. This contributed to the annual value of $63.1 million for FY2024, which is 15103.37% up from last year.
- Camp4 Therapeutics' Common Equity amounted to $58.7 million in Q3 2025, which was up 13690.33% from $40.0 million recorded in Q2 2025.
- In the past 5 years, Camp4 Therapeutics' Common Equity registered a high of $63.1 million during Q4 2024, and its lowest value of -$159.0 million during Q3 2024.
- Moreover, its 3-year median value for Common Equity was $40.0 million (2025), whereas its average is -$25.8 million.
- Examining YoY changes over the last 5 years, Camp4 Therapeutics' Common Equity showed a top increase of 15103.37% in 2024 and a maximum decrease of 4251.46% in 2024.
- Camp4 Therapeutics' Common Equity (Quarter) stood at -$123.7 million in 2023, then surged by 151.03% to $63.1 million in 2024, then dropped by 7.09% to $58.7 million in 2025.
- Its Common Equity was $58.7 million in Q3 2025, compared to $40.0 million in Q2 2025 and $51.6 million in Q1 2025.